Business and Innovation

$100K investment made to Confluence Pharmaceuticals, seeking to treat autism, fragile X symptoms

Indiana University

|

2d

Confluence Pharmaceuticals develops therapies for symptoms that accompany fragile X syndrome and autism spectrum disorder.

Read more about $100K investment made to Confluence Pharmaceuticals, seeking to treat autism, fragile X symptoms